Fidelity Investments
OTLK icon

Fidelity Investments’s Outlook Therapeutics OTLK Stock Holding History

Fidelity Investments’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$1 ﹤0.01% 5553
2026
Q1 		– Sell
-606
Closed -$957 – 5527
2025
Q4 		$957 Buy
606
+500
+472% +$799 ﹤0.01% 5101
2025
Q3 		$112 Sell
106
-170,396
-100% -$295K ﹤0.01% 5196
2025
Q2 		$273K Sell
170,502
-4,735
-3% -$7.55K ﹤0.01% 3198
2025
Q1 		$214K Sell
175,237
-6,284
-3% -$11K ﹤0.01% 3219
2024
Q4 		$343K Buy
181,521
+180,334
+15,192% +$742K ﹤0.01% 3056
2024
Q3 		$6.34K Buy
1,187
+286
+32% +$2.09K ﹤0.01% 4560
2024
Q2 		$6.65K Buy
901
+228
+34% +$1.83K ﹤0.01% 4466
2024
Q1 		$8.04K Sell
673
-621
-48% -$5.02K ﹤0.01% 4352
2023
Q4 		$10.2K Buy
1,294
+1,189
+1,132% +$10.1K ﹤0.01% 4235
2023
Q3 		$464 Sell
105
-345
-77% -$7.63K ﹤0.01% 4720
2023
Q2 		$15.7K Buy
450
+224
+99% +$6.11K ﹤0.01% 3972
2023
Q1 		$4.94K Sell
226
-300
-57% -$6.71K ﹤0.01% 4393
2022
Q4 		$11.4K Sell
526
-7,562
-93% -$164K ﹤0.01% 3965
2022
Q3 		$197K Buy
+8,088
New +$188K ﹤0.01% 3055
2022
Q2 		– Sell
-58
Closed -$1.67K – 5330
2022
Q1 		$2K Buy
58
+54
+1,350% +$1.69K ﹤0.01% 4691
2021
Q4 		$0 Buy
+4
New +$143 ﹤0.01% 4772

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Fidelity Investments's OTLK Position: Q2 2026 in Review

Fidelity Investments opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5553 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in OTLK as recently as Q4 2025.

Fidelity Investments first reported a position in OTLK in Q4 2021 and has held it in 17 quarters since. The position peaked at $343K in Q4 2024. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Fidelity Investments held 1 share of Outlook Therapeutics worth $2 as of Q2 2026.
  • Outlook Therapeutics was a new Fidelity Investments position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5553 holding.
  • Fidelity Investments first reported a position in Outlook Therapeutics in Q4 2021 and has held it in 17 quarters since.
  • Fidelity Investments's Outlook Therapeutics position peaked at $343K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.